Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus

INTRODUCTION: Patients with congenital vascular malformations often suffer from an impaired quality of life (QoL) because of pain and functional disabilities. Previous studies have shown that the mTOR inhibitor sirolimus can reduce complaints and improve QoL in some patients. High target levels of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Harbers, Veroniek E. M., Rongen, Gerard A. P. J. M., van der Vleuten, Carine J. M., Verhoeven, Bas H., de Laat, Peter C. J., van der Horst, Chantal M. A. M., Klein, Willemijn M., Schultze Kool, Leo J., Loo, D. Maroeska W. M. te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190005/
https://www.ncbi.nlm.nih.gov/pubmed/34003452
http://dx.doi.org/10.1007/s12325-021-01758-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190005/
https://www.ncbi.nlm.nih.gov/pubmed/34003452
http://dx.doi.org/10.1007/s12325-021-01758-y

Ejemplares similares